Jeffrey A Allen

Associate Professor, Neurology

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise related to UN SDGs

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

Dive into the research topics where Jeffrey A Allen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

3 Finished
4 Active

A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10%(Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion(Human), 10% (GAMMAGARD LIQUID/KIOVIG)
Allen, J. A.
Baxalta US Inc.
11/14/19 → 5/31/22
Project: Research project
A Phase 1b Study to Evaluate the Safety, Tolerability and Drug-Drug Interactions of ANX005 and Intravenous Immunoglobulin (IVIg) in Subjects with Guillain-Barre Syndrome
Allen, J. A.
ANNEXON, INC
10/1/19 → 9/30/22
Project: Research project
A Phase 3, Multicenter, Randomized,Double-Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy ofZilucoplan in Subjects with Generalized Myasthenia Gravis
Allen, J. A.
RA PHARMACEUTICALS, INC
8/1/19 → 7/31/23
Project: Research project
A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of RVT-2401 in MyastheniaGravis Patients
Allen, J. A.
IMMUNOVANT, INC.
1/1/19 → 12/31/21
Project: Research project
A Phase III, Double-Blind, Randomized, Placebo-Controlle
Allen, J. A.
ViroMed Co., Ltd.
3/1/16 → 12/31/19
Project: Research project

29 Article
8 Review article
4 Chapter
2 Letter
More
- 1 Comment/debate
- 1 Editorial

A Global Survey of Disease Burden in Patients Who Carry a Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy
Allen, J. A., Butler, L., Levine, T. & Haudrich, A., Jan 2021, In: Advances in Therapy. 38, 1, p. 316-328 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Correction to: A Global Survey of Disease Burden in Patients Who Carry a Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy (Advances in Therapy, (2020), 10.1007/s12325-020-01540-6)
Allen, J. A., Butler, L., Levine, T. & Haudrich, A., 2021, (Accepted/In press) In: Advances in Therapy.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Fatigue in chronic inflammatory demyelinating polyneuropathy
Gable, K. L., Attarian, H. & Allen, J. A., Dec 2020, In: Muscle and Nerve. 62, 6, p. 673-680 8 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?
Allen, J. A., Gelinas, D. F., Freimer, M., Runken, M. C. & Wolfe, G. I., Jan 15 2020, In: Journal of the Neurological Sciences. 408, 116497.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Monitoring Clinical Course and Treatment Response in Chronic Inflammatory Demyelinating Polyneuropathy during Routine Care: A Review of Clinical and Laboratory Assessment Measures
Allen, J. A., Merkies, I. S. J. & Lewis, R. A., Sep 2020, In: JAMA Neurology. 77, 9, p. 1159-1166 8 p.
Research output: Contribution to journal › Review article › peer-review
1 Scopus citations